Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Galactose Supplementation for the Treatment of Patients With Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia in Epilepsy (MOGHE): a Pilot Trial

NCT04833322 is registered in ClinicalTrials.gov with Hospital Ruber Internacional as lead sponsor.

NCT NCT04833322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04833322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Galactose Supplementation for the Treatment of Patients With Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia in Epilepsy (MOGHE): a Pilot Trial
Lead sponsor
Hospital Ruber Internacional
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2021
Completion date
October 1, 2021
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory epilepsy, slc35a2-cdg - solute carrier family 35 member a2 congenital disorder of glycosylation